Press Releases

LEXINGTON, Mass. , Jan. 09, 2020 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc . (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the microbiome organ to treat disease and improve human health, today announced the initiation of a research
Read More
Displaying 11 - 13 of 13
Print Page
Email Alerts
RSS
Investor Contact
Search